Drug for spinal muscular atrophy disease already exempt from import duty: FM

Giving a clarification on the issue raised by Congress Vivek K Tankha during Zero Hour on March 17, Sitharaman in Rajya Sabha said the member had day before yesterday stated that there is one medicine to treat spinal muscular atrophy disease which costs about Rs 16 crore and there is a tax component at Rs 7 crore.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news